Norway keeps AstraZeneca vaccine on hold for another three weeks
Norway will delay a decision on whether to resume the use of AstraZeneca’s COVID-19 vaccine until April 15, the Norwegian Institute of Public Health (FHI) said on Friday.
Norway will delay a decision on whether to resume the use of AstraZeneca’s COVID-19 vaccine until April 15, the Norwegian Institute of Public Health (FHI) said on Friday.